GC CELL CORPORATION
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GC Cell is a biotechnology company specializing in cell therapy innovation, offering a fully-integrated value chain from research to commercialization. The company provides comprehensive solutions tailored to its partners, including end-to-end Contract Development and Manufacturing Organization (CDMO) services for cell and gene therapies, specialized bio-logistics, and cell banking. In addition to its service offerings, GC Cell develops proprietary immune cell therapies, with a research focus on NK and T cells. Its flagship product, Immuncell-LC, is an approved adjuvant therapy for patients with hepatocellular carcinoma following tumor removal. The company's mission is to accelerate the development of novel cell and gene therapies to improve clinical outcomes for patients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GC CELL CORPORATION and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
